The Waiting Time of Prostate Cancer Patients in Poland
AbstractBackground: Prostate cancer is the second most common reason of mortality due to cancer among men in Poland. The study aimed to determine the waiting time for diagnosis and treatment of prostate cancer. Methods: The study was carried out on patients treated for prostate cancer from May 2014 to February 2015 at five oncological centres in Poland. The median waiting time was measured from the time cancer was suspected to the histopathological diagnosis (SDI), from the cancer suspicion to the start of treatment (STI) and from the diagnosis to the start of treatment (DTI). Results: 123 males treated for prostate cancer were included for analysis. The median time for SDI, STI and DTI was 7.7, 18.7 and 8.7 weeks, respectively. Place of residence was the only factor which influenced STI (p = 0.003). For patients, who started treatment with radiation therapy DTI was longer than for other patients (p < 0.001). Conclusions: Median times of STI, SDI and DTI for prostate cancer patients in Poland are similar to the intervals described in other countries. Patients, who lived further from an oncology centre waited longer for treatment. The impact of waiting time in the case of prostate cancer on improving the prognosis is still unclear. View Full-Text
Share & Cite This Article
Osowiecka, K.; Nawrocki, S.; Kurowicki, M.; Rucinska, M. The Waiting Time of Prostate Cancer Patients in Poland. Int. J. Environ. Res. Public Health 2019, 16, 342.
Osowiecka K, Nawrocki S, Kurowicki M, Rucinska M. The Waiting Time of Prostate Cancer Patients in Poland. International Journal of Environmental Research and Public Health. 2019; 16(3):342.Chicago/Turabian Style
Osowiecka, Karolina; Nawrocki, Sergiusz; Kurowicki, Marcin; Rucinska, Monika. 2019. "The Waiting Time of Prostate Cancer Patients in Poland." Int. J. Environ. Res. Public Health 16, no. 3: 342.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.